Baring Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$825K Sell
4,428
-388
-8% -$68.7K 0.05% 148
2017
Q2
$829K Sell
4,816
-4,811
-50% -$783K 0.05% 147
2017
Q1
$1.58M Sell
9,627
-15,998
-62% -$2.66M 0.11% 118
2016
Q4
$3.75M Sell
25,625
-22,933
-47% -$3.45M 0.26% 81
2016
Q3
$8.1M Sell
48,558
-1,434
-3% -$242K 0.58% 57
2016
Q2
$7.61M Sell
49,992
-451
-0.9% -$70.1K 0.62% 53
2016
Q1
$7.56M Sell
50,443
-1,972
-4% -$293K 0.63% 50
2015
Q4
$8.51M Sell
52,415
-1,897
-3% -$298K 0.72% 46
2015
Q3
$7.51M Sell
54,312
-9,532
-15% -$1.5M 0.68% 56
2015
Q2
$9.8M Sell
63,844
-7,371
-10% -$1.18M 0.8% 42
2015
Q1
$11.4M Sell
71,215
-26,370
-27% -$4.15M 0.9% 38
2014
Q4
$15.5M Sell
97,585
-9,401
-9% -$1.46M 0.99% 29
2014
Q3
$15M Buy
+106,986
New +$14M 0.89% 35

Other funds holding AMGN

Baring Asset Management's AMGN Position: Q3 2017 in Review

Baring Asset Management reduced its Amgen (AMGN) stake by 8.1% in Q3 2017, selling an estimated $68.7K and leaving 4,428 shares worth $825K. The position accounts for 0.05% of the portfolio, ranked #148.

Baring Asset Management first reported a position in AMGN in Q3 2014 and has held it in 13 quarters since. The position peaked at $15.5M in Q4 2014. 1,605 funds tracked by Wall St. Rank hold AMGN as of Q3 2017.

  • Baring Asset Management held 4,428 shares of Amgen worth $825K as of Q3 2017.
  • Baring Asset Management sold 388 Amgen shares in Q3 2017, an estimated $68.7K.
  • Amgen made up 0.05% of Baring Asset Management's portfolio in Q3 2017, its #148 holding.
  • Baring Asset Management first reported a position in Amgen in Q3 2014 and has held it in 13 quarters since.
  • Baring Asset Management's Amgen position peaked at $15.5M in Q4 2014.
  • 1,605 funds tracked by Wall St. Rank held Amgen as of Q3 2017.

Based on Baring Asset Management's 13F filing for Q3 2017, filed 26 Oct 2017.